CSIMarket
 
10x Genomics Inc   (NASDAQ: TXG)
 

10x Genomics Inc's Suppliers Performance

TXG's Supply Chain




 
TXG Costs vs Sales of Suppliers Growth 10x Genomics Inc's cost of sales deteriorated by -18 % year on year, relative to one quarter ago cost of sales fell by -12.41 % in Q2.

• More on TXG Suppliers



10x Genomics Inc's cost of sales deteriorated by -18 % year on year, compare to one quarter ago cost of sales fell by -12.41 % in Q2.

• More on TXG Suppliers




10x Genomics Inc's Comment on Supply Chain


The company operates manufacturing facilities in Pleasanton, California, Singapore, and Taiwan, all certified to ISO 9001:2015 standards. It sources certain instrument and consumable components from third-party suppliers, with some components obtained from single suppliers and others from qualified secondary sources, including critical reagents, enzymes, and oligonucleotides. Consumables are primarily manufactured in-house, encompassing processes such as gel bead generation, surfactant synthesis, emulsion oil formulation, reagent formulation, tube filling, microfluidic chip production, kit assembly, packaging, and quality control testing. Instrument manufacturing for Chromium, Visium, and Xenium products is outsourced to qualified contract manufacturers certified to ISO 13485, while optical components and the final assembly, integration, and testing of the Xenium instrument are performed internally.

10x Genomics Inc's Comment on Supply Chain


The company operates manufacturing facilities in Pleasanton, California, Singapore, and Taiwan, all certified to ISO 9001:2015 standards. It sources certain instrument and consumable components from third-party suppliers, with some components obtained from single suppliers and others from qualified secondary sources, including critical reagents, enzymes, and oligonucleotides. Consumables are primarily manufactured in-house, encompassing processes such as gel bead generation, surfactant synthesis, emulsion oil formulation, reagent formulation, tube filling, microfluidic chip production, kit assembly, packaging, and quality control testing. Instrument manufacturing for Chromium, Visium, and Xenium products is outsourced to qualified contract manufacturers certified to ISO 13485, while optical components and the final assembly, integration, and testing of the Xenium instrument are performed internally.







TXG's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
10x Genomics Inc 10,932.97 616.57 -75.13 1,178
SUBTOTAL 0.00 0.00 0.00 -


Sources: 10x Genomics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on 10x Genomics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.